Aducanumab FDA Approval for Alzheimer's Disease: The Importance of G…

Anton Porsteinsson

Differentiating Early Signs of Alzheimer Disease From Normal Signs o…

ACHL

J. Galvin

Lewy Body Dementia: The Most Common Disease You Never Heard Of

University of Miami

J. Galvin

AAIC 2024 Insights: Reducing the Effects of Aging on Cognition With …

AAIC 2024 Insights Hub

C. Camargo

How to Use Melatonin in Clinical Practice

IntraBalance

N. Bhopal

Cognitive Disorders

ZINCARE

M. Mataa

Gut Microbiome and the Brain

BRAIN PONDERINGS podcast with Mark Mattson

J. Cryan

Approach to Cognitive Impairment in Adults

ZINCARE

M. Mataa

AAIC 2024 Insights: Potential of Targeting the Alpha-1 Adrenergic Re…

AAIC 2024 Insights Hub

S. G. Pattanashetty

Early Diagnosis of Alzheimer’s Disease

Sharon Cohen

Updates in Dementia

2023 Conference Coverage

P. Tipton

AAIC 2024 Insights: Developing an AI Algorithm to Detect Predictors …

AAIC 2024 Insights Hub

J. Butler

AAIC 2024 Insights: qEEG as Biomarker for Alzheimer's Disease - Inve…

AAIC 2024 Insights Hub

C. Simfukwe

Alzheimer's: Clinical Pearls

Lawrence Robbins

Lewy Body Dementia: The Most Common Disease You Never Heard Of - 2024

AdventHealth

J. Galvin

The Illusion of Progress: Lecanemab in Alzheimer's Disease

Alberto Espay

AAIC 2024 Insights: Plasma Aβ42/Aβ40 and Phospho-Tau217 Concentratio…

AAIC 2024 Insights Hub

R. Rissman

Imaging for Dementia with Clinical Cases

APP2APP Virtual Lectures, Inc

S. Best

A New Era for Brain Health in Primary Care: New Drugs and Diagnostics

University of Kansas Medical Center

J. M. Burns

An Update on Alzheimer's Disease: New Strategies Across the Disease …

Miller Medical Communications

P. Tariot